醫療保健 · Healthcare
開啟互動頁面（K 線、成交價圖）Open interactive page →
CUE · Cue Biopharma, Inc.
內部人交易（Form 4）· Insider trading · 2026-07-01 – 2026-10-22
Cue Biopharma, Inc.（CUE）內部人交易：2026-07-01 至 2026-10-22，內部人公開市場買入 —、賣出 $2.4M；高管董事有效買入 —、有效賣出 —。最近申報 2026-10-14。
買入 Bought—
賣出 Sold$2.4M
有效買入 Effective bought—
有效賣出 Effective sold—
最近申報 Recent filings
| 交易日 | 內部人 | 類型 | 股數 | 價格 | 金額 | |
|---|---|---|---|---|---|---|
| 2026-10-12 | Ray Sumita Chief Legal Compliance Officer, Other | 賣出 Sell | 1,844 | $28.05 | $52K | SEC |
| 2026-10-12 | Lin Shao-Lee Chief Executive Officer, Director | 賣出 Sell | 11,087 | $27.55 | $305K | SEC |
| 2026-10-12 | Meluzio Michael Vincent VP, Prin. Accounting Officer | 賣出 Sell | 1,144 | $28.05 | $32K | SEC |
| 2026-08-13 | Ray Sumita Chief Legal Compliance Officer, Other | 賣出 Sell | 8,829 | $30.09 | $266K | SEC |
| 2026-08-13 | Meluzio Michael Vincent VP, Prin. Accounting Officer | 賣出 Sell | 5,628 | $30.09 | $169K | SEC |
| 2026-08-12 | Lin Shao-Lee Chief Executive Officer, Director | 賣出 Sell | 58,258 | $27.58 | $1.6M | SEC |
「有效」= 高管或董事的公開市場主動買賣，排除 10b5-1 計劃、行權賣出、繳稅賣出、IPO/認購等。
擬出售 Form 144
| 預計出售日 | 申報人 | 股數 | 約金額 | |
|---|---|---|---|---|
| 2026-10-12 | Lin Shao-Lee Officer, Director | 11,087 | $305K | |
| 2026-10-12 | Ray Sumita Officer, CORPORATE SECRETARY | 1,844 | $52K | |
| 2026-08-12 | Lin Shao-Lee Officer, Director | 58,258 | $1.6M | |
| 2026-08-13 | Ray Sumita Officer, CORPORATE SECRETARY | 8,829 | $266K |
內部人 Insiders
Ray Sumita、Lin Shao-Lee、Meluzio Michael Vincent